5 • 716 Ratings
🗓️ 26 April 2018
⏱️ 7 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.6 | Welcome back to the Real Life Pharmacology podcast. |
| 0:04.8 | On today's episode, I'm going to cover calcium channel blockers and more specifically the |
| 0:11.3 | dihydropyridines. |
| 0:14.7 | Common examples of dihydropyridine calcium channel blockers include amelotepine, |
| 0:20.4 | which is brand name Norvask, |
| 0:21.6 | philotapine, brand name plendil, nipetopine, brand name nifetacal. |
| 0:27.6 | Mechanism of action with calcium channel blockers is, as it sounds. |
| 0:33.6 | They block calcium channels, which basically leads to relaxation of smooth muscle and vasodilation, therefore lowering blood pressure. |
| 0:46.8 | Most common use that I see these medications use for is hypertension or high blood pressure. |
| 0:56.2 | Adverse effects? |
| 0:58.6 | Most common adverse effect you're likely going to see is dizziness, lower blood pressure, |
| 1:06.0 | as well as the potential for edema, peripheral edema. So swelling in the ankles, swelling in the lower |
| 1:14.5 | limbs is something that can definitely happen and does happen in clinical practice. This is a dose |
| 1:22.5 | dependent effect. So basically what that means is the higher the dose, the more likely you're going to run into this adverse effect. So basically what that means is the higher the dose, the more likely you're going to run |
| 1:30.4 | into this adverse effect. In clinical practice, what I've seen numerous times, especially in |
| 1:37.5 | patients on numerous medications, where this might slip through the cracks, is in order LISIX soon after starting and or increasing a calcium channel blocker like amylopine. |
| 1:52.0 | So again, look out for those medications that get rid of fluid and help treat edema. |
| 1:58.7 | Be sure we're looking at our medication list prior to adding any type of |
| 2:04.5 | diuretic or water pill. So I mentioned these are dihydropyridines. There is a class of calcium |
| 2:13.3 | channel blockers called non-dihydropyrodines, and they act more so on the heart, which I will |
| 2:20.4 | talk about in another episode for sure. But just remember that amylotapine, philotapine, |
| 2:27.4 | phallotapine, these medications aren't going to act on the heart. So what that means is we don't need to monitor pulse rate typically with these meds. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.